Oral anticoagulation therapy
Virjo, I.; Isokoski, M.
Duodecim; Laaketieteellinen Aikakauskirja 114(15): 1518-1519
1998
ISSN/ISBN: 0012-7183 PMID: 11552241 Document Number: 484315
Document emailed within 1 workday
Related Documents
Ikeda, U.; Shimada, K. 2001: Oral anticoagulation therapy during and after coronary angioplasty Circulation 104(24): E150Spyropoulos, A.C. 2005: Bridging of oral anticoagulation therapy for invasive procedures Current Hematology Reports 4(5): 405-413
Kumar, P.R.; Bherappa; Satyanaryana, G.; Jaishanker, S. 1997: Intestinal intussusception as an unusual complication of oral anticoagulation therapy Indian Heart Journal 49(5): 540-542
Di Nucci, G.D. 2004: Low-dose oral anticoagulation therapy in mechanical heart valve prostheses: the Italian experience Journal of Heart Valve Disease 13(Suppl 1): S86-S87
Van Gelder, I.C.; Crijns, H.J.; Tieleman, R.G.; Brügemann, J.; De Kam, P.J.; Gosselink, A.T.; Verheugt, F.W.; Lie, K.I. 1996: Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation Archives of Internal Medicine 156(22): 2585-2592
Uljas, E.; Karjalainen, M.; Vaara, S.; Reinikainen, M. 2015: Anticoagulation for continuous renal replacement therapy in the intensive care unit: a comparison of dalteparin infusion with regional citrate anticoagulation Duodecim; Laaketieteellinen Aikakauskirja 131(11): 1079-1084
Horstkotte, D.; Bergemann, R.; Oelert, H.; Schulte, H.D.; Laas, J.; Zerkowski, H.R. 1998: Increased acceptance of the International Normalized Ratio (INR) as a monitoring parameter of oral anticoagulation therapy in Germany. GELIA Study Group Zeitschrift für Kardiologie 87(10): 837-843
Tripodi, A.; Cattaneo, M.; Molteni, A.; Cesana, B.M.; Mannucci, P.M. 1998: Changes of prothrombin fragment 1+2 (F 1+2) as a function of increasing intensity of oral anticoagulation--considerations on the suitability of F 1+2 to monitor oral anticoagulant treatment Thrombosis and Haemostasis 79(3): 571-573
van den Besselaar, A.M. 1990: Recommended method for reporting therapeutic control of oral anticoagulant therapy. Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis Thrombosis and Haemostasis 63(2): 316-317
Durán Parrondo, C.; Rodríguez Moreno, C.; Tato Herrero, F.; Alonso Vence, N.; Lado Lado, F.L. 2003: Oral anticoagulation Anales de Medicina Interna 20(7): 377-384
Avello, A.G.; César, J.; Pardo Vigo, A.; Frade, L.J.; Sánchez Godoy, P.; Navarro, J.L. 1984: Hemorrhage in oral anticoagulation Revista Clinica Espanola 172(6): 315-318
Rochat, S.; Büla, C. 2005: Oral anticoagulation in elderly people Revue Medicale Suisse 1(39): 2505-2506; 2509-2511
Duckert, F.; Marbet, G.A. 1977: Control of oral anticoagulation--therapeutic range Schweizerische Medizinische Wochenschrift 107(37): 1308
Camp-Wachsmuth, M.; Humair, J.-P.; Boehlen, F. 2009: Advantages of capillary INR monitoring for oral anticoagulation Revue Medicale Suisse 5(218): 1864-1867
Loeliger, E.A.; van Dijk-Wierda, C.A. 1977: Therapeutically optimal values in oral anticoagulation Nederlands Tijdschrift Voor Geneeskunde 121(31): 1242-1243
Nuevo González, J.A.; Cano Ballesteros, J.C.; Pintor Holguín, E.; Braun Saro, B.; Visús Soler, E.; Sevillano Fernández, J.A. 2008: Oral anticoagulation excess: analysis from an emergency department Revista Clinica Espanola 208(2): 66-70
Chechi, T. 2011: Does the clinical setting matter when performing PCi in a patient on oral anticoagulation? Minerva Cardioangiologica 59(5): 407-409
2015: Dabigatran specific antidote: new safety level in oral anticoagulation MMW Fortschritte der Medizin 157(19): 78-79
Froom, P.; Hermoni, D.; Barak, M. 2003: Oral anticoagulation treatment--control, risks, benefits, and informed consent Harefuah 142(1): 56-60; 77
Casner, P.R. 1996: Inability to attain oral anticoagulation: warfarin-rifampin interaction revisited Southern Medical Journal 89(12): 1200-1203